相关实验视频
Updated: Jul 12, 2025

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.5K
在神经退行性疾病中重叠的神经免疫机制和治疗点
Fabiola De Marchi1, Ivana Munitic2, Lea Vidatic3
1Department of Neurology and ALS Centre, University of Piemonte Orientale, Maggiore Della Carità Hospital, Corso Mazzini 18, 28100 Novara, Italy.
Biomedicines
|October 28, 2023
概括
像阿尔茨海默氏症和帕金森症这样的神经退行性疾病共享免疫点,这表明了常见的治疗方法. 针对免疫功能障碍为这些疾病提供了潜在的治疗策略.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病 神经退行性疾病
- 免疫治疗是一种免疫疗法.
背景情况:
- 成人发病的神经退行性疾病 (阿尔茨海默氏症,帕金森病,ALS,FTD) 和青少年尼曼-皮克型C型疾病表现出共同的免疫点参与.
- 免疫细胞子集 (微细胞,巨细胞,T调控细胞),补充系统和可溶性因子是这些疾病的关键免疫标.
研究的目的:
- 为了比较神经退行性疾病的临床方面.
- 确定常见的致病机制,包括蛋白质聚合,神经退行和神经炎症.
- 探索共享的免疫功能障碍和潜在的治疗策略.
主要方法:
- 神经退行性疾病的临床比较.
- 概述蛋白质聚合和神经炎症的常见途径.
- 对不同神经退行性疾病中的免疫功能障碍的分析.
主要成果:
- 在各种神经退行性疾病中,免疫系统参与的重大重叠.
- 确定有助于神经退行和神经炎症的共同途径.
- 针对共同免疫机制的统一治疗方法的潜力.
结论:
- 免疫失调是神经退行性疾病的共同点,不论发病年龄如何.
- 针对共享的免疫路径为新的治疗干预提供了有希望的途径.
- 免疫疗法,补充阻断和微生物组调节等治疗策略可能有利于多种神经退行性疾病.
更多相关视频
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neurochemical Transmission: Sites of Drug Action
2.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.4K
Alzheimer's Disease: Overview
500
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
500
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
696
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
696

